Clinical Trial Update: A Study of AK111 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating AK111 in healthy subjects has completed. Psoriasis is listed as the condition in the study details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• AK111

Snippet

Sponsor: Akesobio Australia Pty Ltd | Conditions: Psoriasis | Phase 1 | Status: COMPLETED